Chronic Neutrophilic Leukemia (CNL), continued

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Myeloproliferative Neoplasms (retired 6/21/2019). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Myeloproliferative Neoplasms (retired 6/21/2019) (online CE course)
Chronic Neutrophilic Leukemia (CNL), continued

CNL tends to progress rather slowly and has been known to culminate in acute leukemia. Survival rates are variable, ranging from 6 months after diagnosis to more than 20 years.

The treatment options for patients with CNL typically include:
  • Allogeneic bone marrow transplantation
  • Chemotherapy medications including hydroxyurea or interferon